Busse, P. J., Farkas, H., Banerji, A., Lumry, W. R., Longhurst, H. J., Sexton, D. J., & Riedl, M. A. (2018). Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. BioDrugs.
Citação norma ChicagoBusse, Paula J., Henriette Farkas, Aleena Banerji, William R. Lumry, Hilary J. Longhurst, Daniel J. Sexton, and Marc A. Riedl. "Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema With C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies." BioDrugs 2018.
MLA citiranjeBusse, Paula J., et al. "Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema With C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies." BioDrugs 2018.